| 1 |
34336680 | The Basic Research of the Combinatorial Therapy of ABT-199 and Homoharringtonine on Acute Myeloid Leukemia. | 2021 |
1 |
| 2 |
34594375 | Homoharringtonine Synergized with Gilteritinib Results in the Downregulation of Myeloid Cell Leukemia-1 by Upregulating UBE2L6 in FLT3-ITD-Mutant Acute Myeloid (Leukemia) Cell Lines. | 2021 |
1 |
| 3 |
30763586 | Homoharringtonine potentiates the antileukemic activity of arsenic trioxide against acute myeloid leukemia cells. | 2019 Mar 15 |
2 |
| 4 |
31115521 | Triptolide exerts an anti-tumor effect on non‑small cell lung cancer cells by inhibiting activation of the IL‑6/STAT3 axis. | 2019 Jul |
1 |
| 5 |
30205168 | Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP release. | 2018 Dec 1 |
1 |
| 6 |
28966941 | Increased expression of the tight junction protein TJP1/ZO-1 is associated with upregulation of TAZ-TEAD activity and an adult tissue stem cell signature in carfilzomib-resistant multiple myeloma cells and high-risk multiple myeloma patients. | 2017 Jul |
1 |
| 7 |
26467384 | Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2- and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma. | 2016 Mar 1 |
1 |
| 8 |
27480872 | Correction: Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2- and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma. | 2016 Aug 1 |
1 |
| 9 |
28024471 | [Combination of Homoharringtonine with Arsenic Trioxide Induces Apoptosis of Human Acute Myeloid Leukemia Cell Line U937]. | 2016 Dec |
1 |
| 10 |
20971952 | Homoharringtonine reduced Mcl-1 expression and induced apoptosis in chronic lymphocytic leukemia. | 2011 Jan 6 |
1 |
| 11 |
21468038 | Omacetaxine may have a role in chronic myeloid leukaemia eradication through downregulation of Mcl-1 and induction of apoptosis in stem/progenitor cells. | 2011 Jun |
3 |
| 12 |
18028486 | ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms. | 2008 Jan |
1 |